Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.

about

Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.

Item

http://www.wikidata.org/entity/Q47728750

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Long-term outcomes of elderly ...... ed with vitamin K antagonists.

@en

Long-term outcomes of elderly ...... ed with vitamin K antagonists.

@nl

type

Item

label

Long-term outcomes of elderly ...... ed with vitamin K antagonists.

@en

Long-term outcomes of elderly ...... ed with vitamin K antagonists.

@nl

prefLabel

Long-term outcomes of elderly ...... ed with vitamin K antagonists.

@en

Long-term outcomes of elderly ...... ed with vitamin K antagonists.

@nl

P1476

Long-term outcomes of elderly ...... ted with vitamin K antagonists

@en

P2093

A Limacher

http://www.w3.org/2001/XMLSchema#string

B Frauchiger

http://www.w3.org/2001/XMLSchema#string

C Abbal

http://www.w3.org/2001/XMLSchema#string

C M Matter

http://www.w3.org/2001/XMLSchema#string

D Aujesky

http://www.w3.org/2001/XMLSchema#string

D Staub

http://www.w3.org/2001/XMLSchema#string

J Cornuz

http://www.w3.org/2001/XMLSchema#string

J Osterwalder

http://www.w3.org/2001/XMLSchema#string

L Mazzolai

http://www.w3.org/2001/XMLSchema#string

M Aschwanden

http://www.w3.org/2001/XMLSchema#string

P2860

Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis

Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy

Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiation

Design and establishment of a biobank in a multicenter prospective cohort study of elderly patients with venous thromboembolism (SWITCO65+).

The impact of age and CYP2C9 and VKORC1 variants on stable warfarin dose in the paediatric population.

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Risk factors for venous thrombosis - current understanding from an epidemiological point of view.

Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review.

Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly

Risk assessment for recurrent venous thrombosis.

P304

2165-2175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JTH.13810

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anne Angelillo-Scherrer

P577

2017-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28834238

http://www.w3.org/2001/XMLSchema#string

P921

vitamin K